Determination of hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 5, 2007, Pages 1187-1191

  Liu, Fei ^a   Xu, Yu ^a   Gao, Shu ^b   zhang, Jundong ^b   Guo, Qingxiang ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b Hefei Con source Medicine Technology Corporation   (China)

Author keywords

Hydrochlorothiazide; Liquid chromatography; Mass spectrometry

Indexed keywords

HYDROCHLOROTHIAZIDE; IRBESARTAN;

ACCURACY; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; CHROMATOGRAPHY, LIQUID; DIURETICS; DRUG STABILITY; FREEZING; HUMANS; HYDROCHLOROTHIAZIDE; METHANOL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLVENTS; TABLETS; TANDEM MASS SPECTROMETRY; TEMPERATURE; TETRAZOLES; TIME FACTORS; WATER;

EID: 34547754413     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.04.020     Document Type: Article

References (21)

1. Vonaparti A., Kazanis M., and Panderi I. J. Mass Spectrom. 41 (2006) 593-605
2. Rahn K.H. Clin. Exp. Hypertens. A 5 (1983) 157-166
3. Patel R.B., Patel U.R., Rogge M.C., Shah V.P., Prasad V.K., Selen A., and Welling P.G. J. Pharm. Sci. 73 (1984) 359-361
4. Ramakrishna N.V.S., Vishwottam K.N., Manoj S., Koteshwara M., Wishu S., and Varma D.P. Biomed. Chromatogr. 19 (2005) 751-760
5. Wellington K., and Faulds D.M. Drugs 62 (2002) 1983-2005
6. Crespo M.J., and De Mello W.C. Eur. J. Pharmacol. 420 (2001) 133-141
7. Chazova I.E., Ratova L.G., Dmitriev V.V., Sinitsin V.E., and Stukalova O.V. Kardiologiya 43 (2003) 60-65
8. Martina B., Dieterle T., Weinbacher M., and Battegay E. Cardiology 92 (1999) 110-114
9. Middlemost S.J., Tager R., Davis J., and Sareli P. Am. J. Cardiol. 73 (1994) 1092-1097
10. Huang T.M., He Z., Yang B., Shao L.P., Zheng X.W., and Duan G.L. J. Pharm. Biomed. Anal. 41 (2006) 644-648
11. Miller R.B., and Amestoy C. J. Pharm. Biomed. Anal. 10 (1992) 541-545
12. Niopas I., and Daftsios A.C. J. Liq. Chromatogr. Relat. Technol. 25 (2002) 487-494
13. Medvedovici A., Mircioiu C., David V., and Miron D.S. Eur. J. Drug Metabol. Pharmacokinet. 25 (2000) 91-96
14. Richter K., Oertel R., and Kirch W. J. Chromatogr. A 729 (1996) 293-296
15. Azumaya C.T. J. Chromatogr. Biomed. Appl. 532 (1990) 168-174
16. Kuo B.S., Mandagere A., Osborne D.R., and Hwang K.K. Pharm. Res. 7 (1990) 1257-1261
17. Farthing D., Fakhry I., Ripley E.B.D., and Sica D. J. Pharm. Biomed. Anal. 17 (1998) 1455-1459
18. Zendelovska D., Stafilov T., and Milosevski P. Biomed. Chromatogr. 18 (2004) 71-76
19. Takubo T., Okada H., Ishii M., Hara K., and Ishii Y. J. Chromatogr. B 806 (2004) 199-203
20. Fang W., Xie W., Hsieh J.Y.K., and Matuszewski B.K. J. Liq. Chromatogr. Relat. Technol. 28 (2005) 2681-2703
21. U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry on Bioanalytical Method Validation, Federal Register, 2001.